Loan Capital Cambiamento Data
Acadia Pharmaceuticals USD 0 0 2022-06
Bayer EUR 35.11B 1.45B 2023-09
Gilead Sciences USD 23.19B 1.98B 2023-09
Intra Cellular Therapies USD 0 0 2022-06
Neurocrine Biosciences USD 169.5M 500K 2023-03
Teva Pharmaceutical Industries USD 18.5B 203M 2023-09
Ultragenyx Pharmaceutical USD 0 0 2022-06



Biogen Capitale Di Prestito - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2024.